These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13485121)

  • 1. Bleeding syndrome in thrombin-injected rats deficient in fibrinogen and antihemophilic factor.
    BRAYTON RG; ZUCKER MB
    Proc Soc Exp Biol Med; 1957 Nov; 96(2):418-21. PubMed ID: 13485121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Separation of fibrinogen and of the antihemophilic factor A].
    SOULIER JP; GOBBI F; LARRIEU MJ
    Rev Hematol; 1957; 12(4):481-96. PubMed ID: 13518868
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIHEMOPHILIC FACTOR: ITS PRESENCE IN FIBRINOGEN, ASSAY PROBLEMS AND THE STABILITY OF LYOPHILIZED AHF-FIBRINOGEN PREPARATIONS.
    BAUMGARTEN W; SANDERS BE; BELKIN BD; PAGENKEMPER FE; ALBERS WG; CIMINERA JL
    Thromb Diath Haemorrh; 1963 Jul; 143():354-67. PubMed ID: 14081259
    [No Abstract]   [Full Text] [Related]  

  • 4. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION CAUSING HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:273 F. PubMed ID: 14264681
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme studies on human blood. VIII. The effect of fibrinogen concentration on the thrombin clotting time.
    SHINOWARA GY; ROSENFELD L
    J Lab Clin Med; 1951 Feb; 37(2):303-10. PubMed ID: 14814357
    [No Abstract]   [Full Text] [Related]  

  • 6. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION AS A CAUSE OF HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:269-72 C. PubMed ID: 14270015
    [No Abstract]   [Full Text] [Related]  

  • 7. [A SIMPLE MODIFICATION OF THE 1-STEP PROCEDURE FOR DETERMINATION OF THROMBIN TIME, QUANTITY OF FIBRINOGEN AND FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    KUZNIK BI
    Vopr Med Khim; 1964; 10():316-8. PubMed ID: 14221560
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas.
    WAGNER RH; RICHARDSON BA; BRINKHOUS KM
    Thromb Diath Haemorrh; 1958 Apr; 1(1):1-8. PubMed ID: 13569420
    [No Abstract]   [Full Text] [Related]  

  • 9. [PRESERVATION OF ANTIHEMOPHILIC GLOBULIN IN PRESERVED BLOOD].
    RUTBERG RA; MALLER AR; ABDULLAEV GM
    Probl Gematol Pereliv Krovi; 1963 Sep; 8():19-23. PubMed ID: 14119758
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen-fibrin conversion syndrome.
    HODGKINSON CP
    West J Surg Obstet Gynecol; 1956 Dec; 64(12):658-62. PubMed ID: 13381104
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudohemophilia type B; hereditary hemorrhagic diathesis characterized by prolonged bleeding time and decrease in antihemophilic factor.
    SINGER K; RAMOT B
    AMA Arch Intern Med; 1956 Jun; 97(6):715-25. PubMed ID: 13312713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemorrhagic diathesis and activity of the antihemophilic factor in women].
    VERSTRAETE M; VANDENBROUCKE J
    Rev Hematol; 1955; 10(4):665-73. PubMed ID: 13311037
    [No Abstract]   [Full Text] [Related]  

  • 13. THE ACTIVATION AND CONSUMPTION OF FACTOR X IN RECALCIFIED PLASMA. THE EFFECT OF ADDED FACTOR VIII AND RUSSELL'S VIPER VENOM.
    MACFARLANE RG; ASH BJ
    Br J Haematol; 1964 Apr; 10():217-24. PubMed ID: 14141620
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL ANESTHESIA CONFERENCE.
    MARK LC; MARX GF; HENRY EL; KEPES ER; MAZZA L; TIERS FM
    N Y State J Med; 1964 Jul; 64():1860-2. PubMed ID: 14154608
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia.
    GITLIN D; BORGES WH
    Blood; 1953 Aug; 8(8):679-86. PubMed ID: 13066510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation of fibrinogen by thrombin; action of some antagonists after warming of plasma].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1950 Oct; 144(19-20):1338-9. PubMed ID: 14812704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital hemorrhagic syndrome due to deficiency of a prothromboplastic plasma factor different from the antihemophilic factor; hemophilia B].
    BEAUMONT JL; CAYLA A; DUPIN H; BERNARD J
    Sang; 1953; 24(6):488-95. PubMed ID: 13101606
    [No Abstract]   [Full Text] [Related]  

  • 18. Formaldehyde as an inhibitor of clotting of fibrinogen by thrombin.
    WAUGH DF; LIVINGSTONE BJ
    J Phys Colloid Chem; 1951 Mar; 55(3):464-76. PubMed ID: 14825146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coagulation of fibrinogen by thrombin; action of some antagonists in the absence and in the presence of ionized calcium].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1950 Jun; 144(11-12):750-2. PubMed ID: 14783855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.